American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3-Reference-Cited by-同舟云学术

American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3

Published:2021-08-04 Issue:10 Volume:73 Page:
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Curtis Jeffrey R.¹^ORCID,Johnson Sindhu R.²^ORCID,Anthony Donald D.³,Arasaratnam Reuben J.⁴,Baden Lindsey R.⁵,Bass Anne R.⁶^ORCID,Calabrese Cassandra⁷,Gravallese Ellen M.⁵,Harpaz Rafael⁸,Kroger Andrew⁹,Sadun Rebecca E.¹⁰,Turner Amy S.¹¹^ORCID,Williams Eleanor Anderson¹²,Mikuls Ted R.¹³^ORCID

Affiliation:

1. University of Alabama at Birmingham

2. Toronto Western Hospital Mount Sinai Hospital, and University of Toronto Toronto Ontario Canada

3. Louis Stokes Cleveland VA Medical Center MetroHealth Medical Center, and Case Western Reserve University Cleveland Ohio United States

4. VA North Texas Health Care System and University of Texas Southwestern Medical Center Dallas

5. Brigham and Women’s Hospital Boston Massachusetts United States

6. Hospital for Special Surgery and Weill Cornell Medicine New York New York United States

7. Cleveland Clinic Cleveland Ohio United States

8. Harpaz Herman Consultants Atlanta Georgia United States

9. CDC Atlanta Georgia United States

10. Duke University Durham North Carolina United States

11. American College of Rheumatology Atlanta Georgia United States

12. The Permanente Medical Group Union City California United States

13. University of Nebraska Medical Center and VA Nebraska–Western Iowa Health Care System Omaha

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41928

Reference95 articles.

1. Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers, and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR);Van der Heijde D;Arthritis Rheumatol,2018

2. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3

3. US Food and Drug Administration.Vaccines and Related Biological Products Advisory Committee meeting: FDA briefing document Pfizer‐BioNTech COVID‐19 vaccine. December2020. URL:https://www.fda.gov/media/144245/download.

4. US Food and Drug Administration.Vaccines and Related Biological Products Advisory Committee meeting: FDA briefing document Moderna COVID‐19 vaccine. December2020. URL:https://www.fda.gov/media/144434/download.

5. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis and mortality of systemic lupus erythematosus;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Impact of the COVID-19 pandemic on the quality of care for juvenile idiopathic arthritis patients: insights from Thailand;Orphanet Journal of Rare Diseases;2024-09-02

3. COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study;Seminars in Arthritis and Rheumatism;2024-08

4. Risk of Recurrent Noninfectious Uveitis After Coronavirus Disease 2019 Vaccination in the United States;Ophthalmology Science;2024-07

5. Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting;Vaccines;2024-06-18